Israeli bone regeneration biotech CartiHeal has raised $18.3 million to fund a trial that will help it achieve US FDA approval for its cartilage regeneration technology.  CartiHeal already has CE (European) marketing approval.

http://www.globes.co.il/en/article-israel-bone-regeneration-co-cartiheal-raises-183m-1001187527